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a b s t r a c t
Ras proteins are small GTPase functioning as molecular switches that, in response to particular extracel-
lular signalling, as growth factors, activate a diverse array of intracellular effector cascades regulating cell
proliferation, differentiation and apoptosis. Human tumours frequently express Ras proteins (Ha-, Ki-, N-
Ras) activated by point mutations which contribute to malignant phenotype, including invasiveness and
angiogenesis. Despite the common signalling pathways leading to similar cellular responses, studies
clearly demonstrate unique roles of the Ras family members in normal and pathological conditions
and the lack of functional redundancy seems to be explainable, at least in part, by the ability of Ras
isoforms to localize in different microdomains to plasma membrane and intracellular organelles. This
different intracellular compartmentalization could help Ras isoforms to contact different downstream
effectors ﬁnally leading to different biological outcomes.
Interestingly, it has also been shown that Ha- and Ki-Ras exert an opposite role in regulating intracel-
lular redox status.
In this regard we suggest that H-Ras speciﬁc induction of ROS (reactive oxygen species) production
could be one of the main determinants of the invasive phenotype which characterize cancer cells
harbouring H-Ras mutations. In our hypothesis then, while K-Ras (not able to promote oxidative stress)
could mainly contribute to cancer progression and invasiveness through activation of MAPK and PI3 K,
H-Ras-mediated oxidative stress could play a unique role in modulation of intercellular contacts leading
to a loss of cell adhesion and eventually also to a metastatic spread.
 2012 Elsevier Ltd. All rights reserved.
Introduction
Three closely related Ras isoforms, Harvey rat sarcoma viral
oncogene homolog (termed H-Ras), neuroblastoma Ras viral onco-
gene homolog (termed N-Ras) and Kirsten rat sarcoma viral onco-
gene homolog (termed K-Ras), have sequence homology between
residues 1 and 165 corresponding to GDP–GTP binding and effec-
tors interactions motifs. The portion of the sequence which differs
in the three different Ras isoforms is the C-terminal hypervariable
region (HVR), which contains the major motifs for membrane
attachment and targeting to distinct intracellular compartments.
After synthesis on cytosolic polysomes, Ras isoforms undergo
post-translation modiﬁcations which affect their membrane afﬁn-
ity [1]. In particular the lack of hydrophobic acyl groups on K-Ras
facilitates its shuttling between the cell surface and intracellular
organelles [2]; interestingly K-Ras can migrate to mitochondria
and regulate apoptosis [3]. On the other hand palmitoyl groups
on H-Ras make it able to localize preferentially to the lipid rafts [4].
Ras proteins (comprising Ha-Ras, Ki-Ras and N-Ras) activate
different signal pathways responsible for control of proliferation,
cell adhesion, apoptosis and cell migration.
Mutations in the Ras family of proto-oncogenes are found in
30% of all human tumours and in 50% of colon tumours in particu-
lar [5]. The point mutations affect usually residues 12 and 61; in
particular the glycine to valine mutation on residue 12 renders
Ras insensitive to inactivation leading to increased invasion and
metastasis and decreased apoptosis.
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Ras proteins modulate the activity of several downstream
molecular effectors, among them the mitogen activated protein
(MAP) kinases and PI3 K are the most studied [6,7]. Despite their
high degree of sequence homology Ha-, Ki- and N-Ras proteins
exert different biochemical activities [8]. For example it has been
shown a different afﬁnity for downstream molecular effectors as
Raf and phosphoinositide 3-kinase (PI3K) and a unique role of
K-Ras during mouse development [9–11].
Interestingly, published data show also that H-Ras can induce
NADPH-oxidase (Nox) system through activation of ERK 1/2 lead-
ing to an increase in intracellular ROS levels [12–15] while K-Ras,
on the other hand, can determine a resistance to oxidative stress
[16] and it can stimulate the scavenging of ROS by activating
posttranscriptionally the mitochondrial antioxidant enzyme
Mn-superoxide dismutase (Mn-SOD) in a ERK 1/2 dependent
manner [17,15].
Hypothesis
Reactive oxygen species (ROS) exert a role in tumour metasta-
sis; particularly they are involved in epithelial–mesenchymal tran-
sition (EMT), migration, invasion of the tumour cells and
angiogenesis [18–21]. These biological effects are mediated
through activation of MAPK which stimulate several transcrip-
tional factors controlling cancer-associated cellular behaviour:
activation of Smad determines, for example, a decrease in cell
adhesion and an increase in migration and invasion, and activation
of Snail causes a change in cellular shape, referred as epithelial
mesenchymal transition, which is associated with acquisition of
motility and loss of cell adhesion too [22].
The membrane-associated NADPH oxidase system (Nox1), to-
gether with mitochondria, is one of the main sources of ROS within
the cell and its biochemical activity is able to determine a persis-
tent directed cellular migration through exportation of a2b1 inte-
grins to cell surface [23]; it has also been proposed that Nox1 could
be a target for cancer therapy [24]. Intriguing published data
showed that NADPH oxidase-generated ROS are required for the
formation and function of invadopodia, which are cellular struc-
tures required for cellular motility and invasivity; in particular in
a mouse ﬁbrosarcoma model system (Src -3T3 cells) Nox1-derived
ROS showed the ability to stimulate phosphorilation of Tks4 and
Tks5 [25], which are two proteins exerting a main role in the func-
tion of invadopodia [26,27].
Also ROS of mitochondrial origin are related to acquisition of an
invasive phenotype through activation of Ets-1 transcription factor
which determines expression of metalloproteinase or through
down regulation of metalloproteinase inhibitors [28,29].
In favour of a crucial role of ROS in cancer metastasis, it has also
been shown, in animal models, that targeted delivery of catalase,
an enzyme counteracting ROS-related oxidative stress, was able
to inhibit tumour metastasis to the liver, lung and peritoneal or-
gans [30].
We suggest that H-Ras mediated production of ROS, through
activation of Nox system, could be a peculiar molecular mechanism
by which this speciﬁc isoform of the Ras family proteins mediate
the process of cancer cell migration and invasion, leading to metas-
tasis; K-Ras, on the other hand, could be able to stimulate invasion
and migration, through other molecular effectors, probably shared
with H-Ras, as PI3K [31]
Evaluation of hypothesis and discussion
H- and K-Ras are two isoforms of the Ras family proteins but
they have different biological effects. In particular it has been
shown that H-Ras is frequently associated to a more aggressive
and invasive phenotype because it is speciﬁcally able to activate
Rac-MKK3/6-p38 pathway [32] and it could increase MMP-2
[33], urokinase [34], MMP-9 and COX-2 [35], Fyn [36] expression,
while K-Ras has been proposed to play a unique role in initiation
of tumours of endodermal origin via stem cell expansion [37];
interestingly in the latter case H-Ras induced, on the contrary, dif-
ferentiation and growth arrest of these cells. The work by Quinlan
and co-workers [37] seem then point out a speciﬁc role of K-Ras in
tumour initiation, while H-Ras could exert an action at a later
phase of cancer progression inducing metastasis formation.
In this regard, as aforementioned, we speculate that H-Ras could
inducemetastasis of cancer cells through its unique ability to deter-
mine ROS production via activation of the Nox system; in favour of
this argument published data showed that pharmacological inhibi-
tion of this enzymatic complex suppressedMMP-13 (collagenase 3)
expression mediated by H-Ras [38] and that H-Ras overexpression
enhanced NF-kB binding to motifs in the MMP-9 gene promoter
by increasing cellular superoxide production [39]. Interestingly, it
has also been proposed that H-Ras-mediated production of ROS
could be sufﬁcient to induce transformation of transfected rat
kidney epithelial cells; furthermore in vivo studies of tumour for-
mation in nude mice showed that overexpression of glutathione
peroxidase 1, an antioxidant enzyme, and completely suppressed
tumour cell growth [40]. Finally, the evidence that ROS can also
stabilize H-Ras protein inhibiting its proteasomal degradation
[41] lead us to speculate that the protein, inducing ROS production,
could activate a self-stimulatingmechanismwhich probably causes
an increase in intensity and duration of the oncogenic signal. In this
regard it is worthy of mention also the ability of ROS to inhibit
protein tyrosine posphatases [42,43] which are negative regulator
of receptor tyrosine kinase (RTK); given that Ras is usually involved
in signal transduction downstream RTK interaction with growth
factors, H-Ras-mediated increase in intracellular ROS could contrib-
ute to amplify growth factor signalling.
ROS and H-Ras seem then act synergistically determining an
autocatalytic cycle which could cause a drastic increase both in
intensity and duration of signal; in our knowledge K-Ras, on the
other hand, is not able to determine such an autocatalytic cycle
of signalling activation. Furthermore K-Ras, through activation of
MnSOD and catalase, counteract the metastasis-inducing effect of
mitochondrial ROS (Fig. 1).
Fig. 1. Different pathways triggered by H- and K-Ras in regulation of ROS
production. H-Ras, localizing in cellular membrane microdomains close to Nox1
activates it leading to ROS production and biological effects as cell motility, loss of
cell adhesion and invasion. ROS may also, through an unknown mechanism,
counteract proteasome-mediated H-Ras proteolytic degradation. K-Ras, on the
other hand, being able to localize inside mitochondria, positively regulate SOD gene
expression ultimately causing a fall in intracellular ROS levels.
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Both H- and K-Ras exert their opposite role in regulating intra-
cellular redox status through activation of ERK 1/2 downstream
effectors; this seems a paradox, because it is difﬁcult to understand
how the same pathway could determine such an opposite biologi-
cal outcome. In this regard a reasonable explanation appears the
aforementioned ability of the two Ras isoforms to localize in differ-
ent membrane microdomains. The H-Ras signalling complex, enu-
cleating in the lipid rafts [4], could activate ERK 1/2 contiguous to
NADH oxidase complex [44–46]. Furthermore it has been shown
that Rac1, which is induced by H-Ras [47], is sufﬁcient to stimulate
the NADH oxidase complex assembly [48]; H-Ras could then also
activate Nox1 in a Rac1-dependent, ERK 1/2 independent manner.
K-Ras, on the other hand, being able to migrate to mitochondria
[3], could activate the mitochondrial antioxidant enzyme MnSOD;
interestingly Bivona and co-workers [3] showed that mitochondrial
localization of K-Ras depends on phosphorilation on a serine 181
within a polybasic region lacking in H-Ras. From this point of view
the speciﬁc ability of K-Ras to stimulate activity of a mitochondrial
enzyme (MnSOD) could be explained again, as for H-Ras andNADPH
oxidase, by the correlation between protein sequence and speciﬁc
intracellular localization. In this regard it seems very interesting
that a glutamic acid substitution of the four lysine residues at the
polybasic stretch of the COOH terminus of K-Ras, the region also
crucial for mitochondrial translocation, completely abolished the
post-transcriptional activation of MnSOD [17].
Conclusions and future perspectives
In this paper we speculate about the possible crucial role of ROS
in mediating a cellular behaviour similar to metastatization; H-Ras
could have a very important role in stimulating such process being
necessary to ‘‘maintain’’ tumorigenicity while K-Ras, on the other
hand, could be necessary to trigger the early steps of neoplastic
transformation, even if it is involved in cancer cells invasion too.
Ras proteins localize to the plasma membrane where they func-
tion as molecular switches activating signal transduction path-
ways; this localisation depends on complex post-translational
processing which increase proteins hydrophobicity. The crucial
post-translational modiﬁcation, shared by all Ras isoforms, consists
of a prenylation catalysed by the enzyme farnesyltransferase
(PFTase) and this is the reason why one of the promising molecular
therapeutically approaches in the treatment of cancer patients
could be administration of PFTase inhibitor [49]; despite all this
therapy is no speciﬁc because it is directed against all Ras isoforms.
Interestingly, it has been recently reported that hypervariable
region (HVR), consisting of amino acids 166–189 in H-Ras, deter-
mines the invasive/migratory signalling program [50].
We suggest that an ‘‘intelligent anticancer therapy’’ could be di-
rected against this speciﬁc motif of Ha-Ras protein or, alternatively,
against the motif, once identiﬁed, which is responsible of the spe-
ciﬁc activation of Nox system; this could help to drastically reduce
intracellular level of ROS in cancer cells harbouring an activated
H-Ras protein, preventing acquisition of invasive and migratory
phenotype. In our knowledge there are no experimental data
regarding knockdown or silencing of H-Ras in cancer cell lines,
while such experiments were carried out for K-Ras isoform. In par-
ticular, in human lung adenocarcinoma cells, it was showed that
adenovirus-mediated siRNA suppression of activated K-Ras gene
expression caused inhibition of in vitro and in vivo cell growth
[51] and in human pancreatic cancer cells silencing of mutant
K-Ras disrupted the malignant phenotype of pancreatic adenocar-
cinoma cells [52].
ROS, when present at an high intracellular level, are also well
known mediators of cell death so an alternative ROS-based
anticancer therapy could be the stimulation of their production
to cause apoptosis in cancer cells; such therapeutic strategy should
be oriented, in a high speciﬁc manner, only towards cancer cells
but, in our opinion, it seems very difﬁcult to achieve.
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